Covid-19 Vaccine from Pfizer and BioNTech Shows Positive Results
By News
Published 4 years ago on
July 1, 2020
Share
[aggregation-styles]
Stat News
An experimental Covid-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects not deemed serious.
The first clinical data on the vaccine were disclosed Wednesday in a paper released on medRXiv, a preprint server, meaning it has not yet been peer-reviewed or published in a journal.
“We still have a ways to go and we’re testing other candidates as well,” said Philip Dormitzer, the chief scientific officer for viral vaccines at Pfizer’s research laboratories. “However, what we can say at this point is there is a viable candidate based on immunogenicity and early tolerability safety data.”
The study showed that the vaccine generated antibodies against SARS-CoV-2, the virus that causes Covid-19, and some of these antibodies were neutralizing, meaning that they appear to prevent the virus from functioning.
Fourteen Covid-19 vaccines are currently in human trials, according to the Milken Institute, including entrants from Inovio, CanSino, AstraZeneca, and Moderna. More are expected to start soon, including entrants from Merck, Johnson & Johnson, and Sanofi. In total, 178 vaccines are in various stages of development.
Read More →
Stat News
An experimental Covid-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects not deemed serious.
The first clinical data on the vaccine were disclosed Wednesday in a paper released on medRXiv, a preprint server, meaning it has not yet been peer-reviewed or published in a journal.
“We still have a ways to go and we’re testing other candidates as well,” said Philip Dormitzer, the chief scientific officer for viral vaccines at Pfizer’s research laboratories. “However, what we can say at this point is there is a viable candidate based on immunogenicity and early tolerability safety data.”
The study showed that the vaccine generated antibodies against SARS-CoV-2, the virus that causes Covid-19, and some of these antibodies were neutralizing, meaning that they appear to prevent the virus from functioning.
Fourteen Covid-19 vaccines are currently in human trials, according to the Milken Institute, including entrants from Inovio, CanSino, AstraZeneca, and Moderna. More are expected to start soon, including entrants from Merck, Johnson & Johnson, and Sanofi. In total, 178 vaccines are in various stages of development.
Read More →
By Matthew Herper | 1 July 2020
RELATED TOPICS:
California Legislation Wants to Uncover the ‘Hidden Homicides’ of Domestic Violence
Crime /
1 day ago
Fresno Oops? Garbage Hike Protest Vote Delayed by Error
Politics /
2 days ago
Trump’s Potential VP Pick Boasts About Executing Puppy
Politics /
2 days ago
Trita Parsi: Blind Support for Israel Erodes Western Democracies
Opinion /
2 days ago
Fresno Trash Hauler’s Response to Overpayments: We Followed the City’s Rules
Politics /
2 days ago
Which Six QBs Were Selected in the Top 12 of the NFL Draft?
Sports /
2 days ago
Nuggets Close to Sweeping Lakers After Game 3 Win
Sports /
2 days ago
Jose Ramirez: ‘I Want to Make a Statement and Put on a Show’
Sports /
2 days ago
California Charter School Battles Intensify as Education Finances Get Squeezed
California’s public schools, with nearly 6 million students, are feeling the financial impacts of a quintuple whammy.
Dan Walters
CalMatte...
Opinion /
56 mins ago
Categories
Latest
Videos
Opinion /
56 mins ago
California Charter School Battles Intensify as Education Finances Get Squeezed
Crime /
1 hour ago
California Officials Debate Prop. 47 Changes to Curb Crime. On the Street, Answers Aren’t That Simple.
Crime /
1 day ago
California Legislation Wants to Uncover the ‘Hidden Homicides’ of Domestic Violence
Politics /
2 days ago
Fresno Oops? Garbage Hike Protest Vote Delayed by Error
Politics /
2 days ago
Trump’s Potential VP Pick Boasts About Executing Puppy
Opinion /
2 days ago